Cytosorbents Corp
CTSO
CTSO
43 hedge funds and large institutions have $20.9M invested in Cytosorbents Corp in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
2.31% more ownership
Funds ownership: 8.82% → 11.13% (+2.3%)
5% more call options, than puts
Call options by funds: $484K | Put options by funds: $462K
Holders
43
Holding in Top 10
–
Calls
$484K
Puts
$462K
Top Buyers
| 1 | +$1.47M | |
| 2 | +$992K | |
| 3 | +$798K | |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$396K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$336K |
Top Sellers
| 1 | -$760K | |
| 2 | -$337K | |
| 3 | -$253K | |
| 4 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$117K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$35K |